Discovery of gene mechanism could bring about new ways to treat metastatic cancer: related news

Discovery of gene mechanism could bring about new ways to treat metastatic cancer

Virginia Commonwealth University and VCU Massey Cancer Center researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 without harming healthy ones, a discovery that could lead to new therapeutic strategies to fight metastatic disease.

Discovery of gene mechanism could bring about new ways to treat metastatic cancer

Researchers identify mechanism used by therapeutically active antitumor cytokine gene able to induce potent bystander antitumor effect in cancer cells

Discovery of gene mechanism could lead to new therapeutic strategies to fight metastatic disease

Add our medical news to del.icio.us - Discovery of gene mechanism could lead to new therapeutic strategies to fight metastatic disease

EntreMed receives new patent for 2-Methoxyestradiol analogs

Add our medical news to digg - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to NewsVine - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Fark - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Furl - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Shadows - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to YahooMyWeb - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Reddit -EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to StumbleUpon - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Facebook - EntreMed receives new patent for 2-Methoxyestradiol analogs

Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis

(PHILADELPHIA) Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have made a key discovery about the mechanism of breast cancer metastasis, the process by which cancer spreads. Focusing on a gene dubbed "Dachshund," or DACH1, they are beginning to pinpoint new therapeutic targets to halt the spread of cancer.

Nanomaterials key to new strategies for blocking metastasis

Add our medical news to digg - Nanomaterials key to new strategies for blocking metastasis Add our medical news to NewsVine - Nanomaterials key to new strategies for blocking metastasis Add our medical news to Fark - Nanomaterials key to new strategies for blocking metastasis Add our medical news to Furl - Nanomaterials key to new strategies for blocking metastasis Add our medical news to Shadows - Nanomaterials key to new strategies for blocking metastasis Add our medical news to YahooMyWeb - Nanomaterials key to new strategies for blocking metastasis Add our medical news to Reddit -Nanomaterials key to new strategies for blocking metastasis Add our medical news to StumbleUpon - Nanomaterials key to new strategies for blocking metastasis Add our medical news to Facebook - Nanomaterials key to new strategies for blocking metastasis

Discover of key patterns in gene packaging

Add our medical news to digg - Discover of key patterns in gene packaging Add our medical news to NewsVine - Discover of key patterns in gene packaging Add our medical news to Fark - Discover of key patterns in gene packaging Add our medical news to Furl - Discover of key patterns in gene packaging Add our medical news to Shadows - Discover of key patterns in gene packaging Add our medical news to YahooMyWeb - Discover of key patterns in gene packaging Add our medical news to Reddit -Discover of key patterns in gene packaging Add our medical news to StumbleUpon - Discover of key patterns in gene packaging Add our medical news to Facebook - Discover of key patterns in gene packaging

LSU Health Sciences Center Inventor Awarded Patent for New Procedure to Detect Cancer Spread

NEW ORLEANS, June 24 (AScribe Newswire) -- Eugene A. Woltering, MD, FACS, The James D. Rives Professor of Surgery and Chief of the Sections of Surgical Oncology & Endocrine Surgery at LSU Health Sciences Center New Orleans, has been awarded a US Patent for a one-step method to rapidly identify "sentinel nodes;" the lymph nodes most likely to contain early metastasis from a primary cancer. Preliminary research indicates that the procedure which consists of injection of a radiolabeled dye around a cancer can identify sentinel nodes that receive lymphatic drainage from the tumor within 10 minutes. Dr. Woltering's patent is based on linking a radioactive iodine molecule to the blue dye commonly used in these sentinel node procedures. One of the major ways to determining the prognosis of a cancer involves determining whether the cancer has met

LegalView Informs Mesothelioma Blog Readers of A New Clinical Trial Available for Victims of Asbestos-Induced Lung Cancer

blog on an opportunity for pleural mesothelioma cancer victims to participate in a clinical trial being conducted at the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center. The clinical trial hopes to improve surgical and radiation treatments for patients of pleural mesothelioma cancer. Currently, the most common treatment for patients of the asbestos-induced cancer is removal of the victim's lung. Individuals who suffer from pleural mesothelioma or any other form of mesothelioma cancer are advised to speak with an experienced

LegalView Informs Mesothelioma Blog Readers of A New Clinical Trial Available for Victims of Asbestos-Induced Lung Cancer

(EMAILWIRE.COM, July 08, 2008 ) Denver, CO - LegalView.com, the number one legal resource on the Web, offered information through its mesothelioma information (http://mesothelioma.legalview.com/blog ) blog on an opportunity for pleural mesothelioma cancer victims to participate in a clinical trial being conducted at the Mesothelioma Center at New York-Presbyterian Hospital and Columbia University Medical Center. The clinical trial hopes to improve surgical and radiation treatments for patients of pleural mesothelioma cancer. Currently, the most common treatment for patients of the asbestos-induced cancer is removal of the victim's lung. Individuals who suffer from pleural mesothelioma or any other form of mesothelioma cancer are advised to speak with an experienced mesothelioma lawyer (http://mesothelioma.

Discovery of Gene Mutation Leading to One Type of Scoliosis Opens New Area of Study in Spine Development

Senior author of an article in Nature Genetics is available to provide details on the discovery of a gene and molecular mechanism leading to an inherited form of scoliosis.

Cancer Resistance Technique Moves To Human Trials

TaeKwonDood tips us to news that a new cancer resistance treatment is going into clinical trials after being quite successful at eradicating cancer in mice. Researchers discovered that certain white blood cells called granulocytes from cancer-immune mice were able to cure cancer in other mice. Now, doctors are putting out the call for healthy granulocyte donors in order to test how well it works on humans. The article quotes lead researcher Zheng Cui saying, "In mice, we've been able to eradicate even highly aggressive forms of malignancy with extremely large tumors. Hopefully, we will see the same results in humans. Our laboratory studies indicate that this cancer-fighting ability is even stronger in healthy humans."

ROCK BAND CONTINUES TO DEBUT NEW SINGLES IN DOWNLOAD CATALOG WITH NEW RELEASES FROM STAIND, SCARS ON BROADWAY AND THE NEW NO2

ROCK BAND™ CONTINUES TO DEBUT NEW SINGLES IN DOWNLOAD CATALOG WITH NEW RELEASES FROM STAIND, SCARS ON BROADWAY AND THE NEW NO2

Patent bid sparks cancer-test price fears

A decision by Genetic Technologies could make breast cancer examinations more expensive, according to Cancer Australia. Genetic holds the Australian and New Zealand patent licences for a test that detects mutations in breast cancer genes, and recently announced plans to use its patent rights to conduct all future testing itself. Women with the defective gene have an 85 per cent change of contracting the disease, against a community-wide average of around nine per cent. Cancer Council Australia CEO, Ian Olver, said allowing genes to be patented could be problematic in the long term and could compromise the Human Genome Project

Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression

Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression

::: Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression

Alnylam Consolidates Intellectual Property for RNA Activation (RNAa), a New Biological Discovery for Activation of Gene Expression

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, Aug. 18 /PRNewswire/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the University of New Mexico Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

Olympic Gold Medalist Inspires Cancer Patients Through Blog

BEIJING, Aug 18, 2008 /PRNewswire via COMTEX/ -- Dick Fosbury, gold medalist from the 1968 Olympic Games in Mexico City and innovator of the high jump technique dubbed the "Fosbury Flop," which revolutionized the sport and is now considered its standard, was stricken by cancer lymphoma in March. After undergoing surgery, radiation and chemotherapy treatment at the University of New Mexico Cancer Center, the State of New Mexico's Official Cancer Center based on the UNM campus in Albuquerque, NM, Fosbury is currently attending the 2008 Olympics Games in Beijing to celebrate the 40th anniversary of the "Fosbury Flop" and inspire cancer patients throughout the world.

Discovery of major genetic cause of colorectal cancer

Add our medical news to StumbleUpon - Discovery of major genetic cause of colorectal cancer Add our medical news to Facebook - Discovery of major genetic cause of colorectal cancer

LSUHSC inventor awarded patent for new procedure to detect cancer spread

New Orleans, LA Eugene A. Woltering, MD, FACS, The James D. Rives Professor of Surgery and Chief of the Sections of Surgical Oncology & Endocrine Surgery at LSU Health Sciences Center New Orleans, has been awarded a US Patent for a one-step method to rapidly identify "sentinel nodes;" the lymph nodes most likely to contain early metastasis from a primary cancer. Preliminary research indicates that the procedure which consists of injection of a radiolabeled dye around a cancer can identify sentinel nodes that receive lymphatic drainage from the tumor within 10 minutes.

Applied Discovery(R) Enhances E-Discovery Online Law Library

a leader in comprehensive electronic discovery products and services, today announced the relaunch of its corporate website, which serves in part as a comprehensive e-discovery resource. In 2000, Applied Discovery was the first to offer an online law library dedicated to the topic of e-discovery, and the website has been continually updated through the years. Today

New Discovery Proves Selfish Gene Exists

A new discovery by a scientist from The University of Western Ontario provides conclusive evidence which supports decades-old evolutionary doctrines long accepted as fact.

New Discovery Proves 'Selfish Gene' Exists

A new discovery by a scientist from The University of Western Ontario provides conclusive evidence which supports decades-old evolutionary doctrines long accepted as fact.

Search took 1.66 seconds.